← Back to Search

Colonoscopy Techniques for Inflammatory Bowel Disease

N/A
Waitlist Available
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
History of UC or colonic Crohn's disease or unclassified colitis patients with or without colonic adenoma history
Mucosal lesion involves ≥ 1/3 of the colon
Must not have
History of total colectomy
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying whether one colonoscopy technique is better than another for detecting colon cancer in patients with IBD.

Who is the study for?
This trial is for adults over 18 with a history of Ulcerative Colitis, Crohn's disease affecting the colon, or unclassified colitis lasting at least eight years, or any duration if also diagnosed with primary sclerosing cholangitis. Participants must have significant colon involvement and not had a total colectomy or recent colonoscopy.
What is being tested?
The study compares two techniques to screen for cancer in patients with long-term IBD: High Definition Colonoscopy (HDC) versus Dye Spraying Chromocolonoscopy (DSC), using high-definition cameras to detect abnormal growths in the colon.
What are the potential side effects?
Potential side effects may include discomfort from the procedure, reactions to dye used in DSC such as allergic responses, and risks typically associated with standard colonoscopies like bleeding or perforation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a history of ulcerative colitis, Crohn's disease, or unspecified colitis, with or without a history of colon polyps.
Select...
My colon lesion affects more than one-third of it.
Select...
I was diagnosed over 8 years ago or have primary sclerosing cholangitis.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had my entire colon removed.
Select...
I am unable to understand and agree to the study's details on my own.
Select...
I have had colorectal cancer in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High Definition White Light ColonoscopyExperimental Treatment1 Intervention
Group II: Dye Spraying Chromo-colonoscopyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
861 Previous Clinical Trials
12,932,326 Total Patients Enrolled

Media Library

Dye Spraying Chromocolonoscopy Clinical Trial Eligibility Overview. Trial Name: NCT04191655 — N/A
Inflammatory Bowel Disease Research Study Groups: Dye Spraying Chromo-colonoscopy, High Definition White Light Colonoscopy
Inflammatory Bowel Disease Clinical Trial 2023: Dye Spraying Chromocolonoscopy Highlights & Side Effects. Trial Name: NCT04191655 — N/A
Dye Spraying Chromocolonoscopy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04191655 — N/A
~70 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top